A womans wearing blue gloves holds up a vial under a fume hood.
Duke's PRIME-PREP Program helped Gabriella Torres get the research experience she needed to become a PhD student in the Duke University Department of Integrative Immunobiology.

Filling in the Gaps

Published

A young woman in front of a fume hood.
Duke's PRIME PREP program helped Gabriella Torres achieve her goal of being accepted into the Duke PhD program in integrative immunobiology. Photo by Eamon Queeney/Duke University School of Medicine.
 

When Gabriella Torres was eight, she needed steroids to control asthma and allergies. Then her allergist recommended she take up swimming, and it helped. When she was nine, her younger brother was diagnosed with leukemia. He was treated and recovered. But watching him go through that left an impression.

As she got older, Torres had nothing but questions. Why did swimming improve her asthma? Why did her brother get so sick? And why did treatment work for him when it doesn’t for so many other children?

Torres was driven to find the answers. In college at New York University, she thought about becoming a pediatric oncologist; she pursued research experiences recommended for students interested in medicine. But then during her junior year an internship at a pharmaceutical company got her interested in pursuing a PhD. “I had never heard of getting a PhD before that,” said Torres, who is from New York City, where her parents are chefs. “But I was able to see that I could use my love of thinking critically about problems long term but still work on a project that relates directly to helping people.”

Torres was on the swim team in college and spent much of her free time training. But she got as much research experience as she could, then applied to the integrative immunobiology PhD program at Duke University School of Medicine in 2023.

Torres didn’t get in. Her goal of becoming a scientist could have ended there. Instead, she received a call from Johnna Frierson, PhD, associate dean of equity, diversity, and inclusion for the basic sciences at the School of Medicine, asking her if she’d be interested in applying for Duke’s PRIME PREP Program, which provides a year of research experience to recent undergraduates.

Torres interviewed for PRIME PREP and got in, then she spent time at Duke conducting research in the lab of Stacy Horner, PhD, associate professor in integrative immunobiology.

"

I was able to work 40 hours a week in a lab and learn how to conduct a project, how to think critically about next steps, how to analyze my data. Those were all experiences that I had done very surface level in the past. It really gave me a different perspective as to what it takes to be a scientist. And I wouldn’t have had that experience somewhere else.

"
Gabriella Torres / PhD student in the Department of Integrative Immunobiology

“I was able to work 40 hours a week in a lab and learn how to conduct a project, how to think critically about next steps, how to analyze my data,” Torres said. “And those were all experiences that I had done very surface level in the past. It really gave me a different perspective as to what it takes to be a scientist. And I wouldn’t have had that experience somewhere else.”

Torres also participated in professional development activities, including the annual Biomedical Research Conference for Minoritized Students, where she talked to other young scientists and to representatives of graduate schools from all over the country.

After PRIME PREP, Torres got admitted to seven graduate schools. She chose to enroll at Duke, and she’s now a first-year PhD student in the Department of Integrative Immunobiology. She didn’t want to leave the Duke community, she said. “The immunology program is on the smaller side, and that makes it feel more welcoming. I like being able to walk down Research Drive and wave to people and ask how their day is going.”

She’s a peer mentor for PRIME PREP this year, and she is excited that her younger brother is currently studying molecular genetics and microbiology at the University of Vermont. “He learned about a PhD through me, so now that’s his goal,” she said.

PRIME PREP is just one effort at Duke aimed at keeping talented people from all backgrounds on the path to becoming scientists and physicians.

Gerry Blobe, MD, PhD, director of education and training for Duke Cancer Institute, describes the goal of DCI’s efforts like this: “If someone wants to get involved in cancer, whether it’s research or clinical care, whatever level they are, is there a way for them to do that? And even more importantly, is there a way to make sure that it sticks?”

Many of these programs are federally funded, but donor support can help make the experiences better, Blobe said. “Offering team-building events, scientific skills courses, ability to take graduate level classes or computers to the participants — all of that is something that donors can help with,” he said.

Four diverse students sit at a round table.
Durham-area high-school students participating in HackBio.

Below are just a few examples of these efforts.

Cancer Career Exploration Day

Who: Undergraduates from Minority Serving Institutions and Historically Black Colleges and Universities
What: A one-day visit to hear about career options at Duke Cancer Institute, as well as how to apply to medical school and graduate school.
The goal: Teach college students about careers in cancer care and research.

Prime Prep Program 

Who: Recent undergraduates from groups under-represented in medicine
What: They spend a year at Duke conducting research and participating in professional development activities.
The goal: Increase enrollment in graduate school among groups underrepresented in medicine.

Hack Bio

Who: Durham-area high school students from groups under-represented in science.
What: They visit Duke campus over four days to work together on projects related to human health and the environment, listen to speakers about topics such as college life and science communication, and work in teams to pitch a solution to an environmental problem to a panel of expert judges.
The goal: To get young people excited about careers in science.

Diversity Supplement Matching Event 

Who: Undergraduates, recent graduates, graduate students, and postdocs from Duke and other universities who are members of groups underrepresented in medicine. Underrepresented groups include racial and ethnic groups, individuals with disabilities, and individuals from disadvantaged backgrounds.
What: A one-day event to match these trainees to Duke faculty who have a federal grant that is eligible for a diversity supplement (additional funding to support underrepresented scientists in biomedical and behavioral research).
The goal: Increase the number of Duke faculty who leverage diversity supplements to enhance work on their existing federal grant while contributing to training a diverse workforce.

Prime Summer Research Program

Who: Rising college juniors and seniors
What: 8-week program in Duke Cancer Institute labs
The goal: Give promising undergraduates better understanding of how laboratory discoveries can be translated to cancer treatment.

This article was originally published in the Fall 2024 Breakthroughs. Read more about DCI's breakthrough research and patient care in this biannual magazine.  

Written By

Angela Spivey smiles

Angela Spivey

Duke University School of Medicine

Related News

A family and their two dogs smiling on a couch.
Cancer survivor Iris Bugbee with her husband, Greg, daughter Mila, and corgis, Candi and Charli, at her home in Fuquay Varina in 2024. Bugbee participated in a clinical trial aimed at helping young adults battling cancer learn strategies to ease their post-treatment symptom burden through things like mindfulness and physical activity. Photo by Eamon Queeney/Duke University School of Medicine.
Article

Helping Young Adults Move Forward after Cancer

Being diagnosed with cancer and going through treatment isn’t easy for anyone. For people diagnosed as young adults (ages 18-39), the experience comes with some unique challenges.“This is an age of transition,” said Caroline Dorfman, PhD, a clinical psychologist at the Duke Cancer Institute. People in this age group are often in the midst of reaching milestones such as graduation, landing a job, building a friend group, getting married, and having children, she said. “One of the things we hear from our patients,” she said, “is that the cancer diagnosis stops them in their tracks from being able to move forward on life milestones.”Even after treatment ends, life doesn’t suddenly switch back to normal. Physical symptoms like pain and fatigue can linger, and emotional distress is common during the post-treatment period. Multiple follow-up appointments can present financial and logistical difficulties as well as emotional reminders of cancer.“Sometimes they just want the cancer behind them and to get back to doing what matters to them,” Dorfman said. “The trouble is that when they are in the midst of treatment, they are just trying to get through it, and they don’t stop to process the experience.”That emotional processing often happens after the last chemo treatment or radiation session.To support young adults during this vulnerable period, Dorfman has designed a 10-week program that aims to give them the tools they need to navigate physical and emotional symptoms and learn how to successfully manage their new lives as cancer survivors.

Duke Cancer Institute Blog
Newspaper Image Article

Introducing Fall 2024 Breakthroughs

AT DUKE CANCER INSTITUTE (DCI), we strive to be the employer of choice for professionals in cancer fields and to ensure that the next generation of physicians and scientists represents the communities we serve. A diverse cancer workforce improves patient outcomes and leads to creative solutions and novel approaches in cancer research and patient care.In this issue of Breakthroughs, you will meet just a few of the people working to invigorate the cancer workforce, as well as a student pursuing her goal of earning a PhD in integrative immunobiology thanks to a federally funded DCI effort aimed at bringing more recent college graduates into the sciences.Also in this issue, you’ll learn one way in which DCI is continuing to innovate in treating the whole person, not just the cancer. An initial clinical trial of a new structured support program to help young adults successfully manage their new lives as cancer survivors helped researcher Caroline Dorfman, PhD, win a MERIT award from the National Institutes of Health to conduct a larger trial of this intervention. This long-term grant recognizes exceptional researchers whose work shows significant promise.None of these efforts, and many others, would be possible without our donors and friends. Thank you for all that you do in helping us shape the future of cancer care and research.Michael B. Kastan, MD, PhDExecutive Director, Duke Cancer InstituteWilliam and Jane Shingleton Professor of Pharmacology and Cancer BiologyThis article was originally published in the Fall 2024 Breakthroughs. Read more about DCI's breakthrough research and patient care in this biannual magazine.

Duke Cancer Institute Blog

Related News

A family and their two dogs smiling on a couch.
Cancer survivor Iris Bugbee with her husband, Greg, daughter Mila, and corgis, Candi and Charli, at her home in Fuquay Varina in 2024. Bugbee participated in a clinical trial aimed at helping young adults battling cancer learn strategies to ease their post-treatment symptom burden through things like mindfulness and physical activity. Photo by Eamon Queeney/Duke University School of Medicine.
Article

Helping Young Adults Move Forward after Cancer

Being diagnosed with cancer and going through treatment isn’t easy for anyone. For people diagnosed as young adults (ages 18-39), the experience comes with some unique challenges.“This is an age of transition,” said Caroline Dorfman, PhD, a clinical psychologist at the Duke Cancer Institute. People in this age group are often in the midst of reaching milestones such as graduation, landing a job, building a friend group, getting married, and having children, she said. “One of the things we hear from our patients,” she said, “is that the cancer diagnosis stops them in their tracks from being able to move forward on life milestones.”Even after treatment ends, life doesn’t suddenly switch back to normal. Physical symptoms like pain and fatigue can linger, and emotional distress is common during the post-treatment period. Multiple follow-up appointments can present financial and logistical difficulties as well as emotional reminders of cancer.“Sometimes they just want the cancer behind them and to get back to doing what matters to them,” Dorfman said. “The trouble is that when they are in the midst of treatment, they are just trying to get through it, and they don’t stop to process the experience.”That emotional processing often happens after the last chemo treatment or radiation session.To support young adults during this vulnerable period, Dorfman has designed a 10-week program that aims to give them the tools they need to navigate physical and emotional symptoms and learn how to successfully manage their new lives as cancer survivors.

Duke Cancer Institute Blog
Newspaper Image Article

Introducing Fall 2024 Breakthroughs

AT DUKE CANCER INSTITUTE (DCI), we strive to be the employer of choice for professionals in cancer fields and to ensure that the next generation of physicians and scientists represents the communities we serve. A diverse cancer workforce improves patient outcomes and leads to creative solutions and novel approaches in cancer research and patient care.In this issue of Breakthroughs, you will meet just a few of the people working to invigorate the cancer workforce, as well as a student pursuing her goal of earning a PhD in integrative immunobiology thanks to a federally funded DCI effort aimed at bringing more recent college graduates into the sciences.Also in this issue, you’ll learn one way in which DCI is continuing to innovate in treating the whole person, not just the cancer. An initial clinical trial of a new structured support program to help young adults successfully manage their new lives as cancer survivors helped researcher Caroline Dorfman, PhD, win a MERIT award from the National Institutes of Health to conduct a larger trial of this intervention. This long-term grant recognizes exceptional researchers whose work shows significant promise.None of these efforts, and many others, would be possible without our donors and friends. Thank you for all that you do in helping us shape the future of cancer care and research.Michael B. Kastan, MD, PhDExecutive Director, Duke Cancer InstituteWilliam and Jane Shingleton Professor of Pharmacology and Cancer BiologyThis article was originally published in the Fall 2024 Breakthroughs. Read more about DCI's breakthrough research and patient care in this biannual magazine.

Duke Cancer Institute Blog